aluates Reports

$ 0.0

Automative

Global Factor IX Complex Drug Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-8I13121

Global Factor IX Complex Drug Market Research Report 2023

BUY CHAPTERS

Global Factor IX Complex Drug Market Research Report 2025

Code: QYRE-Auto-8I13121

Report

May 2025

Pages:77

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

CSL Behring

Grifols S A

Octapharma AG

Prothya Biosolutions

Takeda

Factor IX Complex Drug Market Size

The global market for Factor IX Complex Drug was valued at US$ 1043 million in the year 2024 and is projected to reach a revised size of US$ 2240 million by 2031, growing at a CAGR of 11.7% during the forecast period.

Factor IX Complex Drug Market

Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.

The market factors is increasing prescription of anticoagulants, especially warfarin, as well as rising prevalence of bleeding disorders. Additionally, PCC offers various advantages over Fresh-frozen plasma and others, making it a more suitable option for life-threatening conditions. Apart from this, active government support for the use of 4-factor PCC products such as Kcentra and positive recommendations are anticipated to provide considerable momentum to the market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Factor IX Complex Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Factor IX Complex Drug.

The Factor IX Complex Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Factor IX Complex Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Factor IX Complex Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Factor IX Complex Drug Market Report

Report Metric	Details
Report Name	Factor IX Complex Drug Market
Accounted market size in year	US$ 1043 million
Forecasted market size in 2031	US$ 2240 million
CAGR	11.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Beriplex Profilnine Octaplex Prothromplex Cofact Other
Segment by Application	Hemophilia B Acquired Coagulation Factor Deficiency
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Factor IX Complex Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Factor IX Complex Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Factor IX Complex Drug Market growing?

Ans: The Factor IX Complex Drug Market witnessing a CAGR of 11.7% during the forecast period 2025-2031.

What is the Factor IX Complex Drug Market size in 2031?

Ans: The Factor IX Complex Drug Market size in 2031 will be US$ 2240 million.

Who are the main players in the Factor IX Complex Drug Market report?

Ans: The main players in the Factor IX Complex Drug Market are CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda

What are the Application segmentation covered in the Factor IX Complex Drug Market report?

Ans: The Applications covered in the Factor IX Complex Drug Market report are Hemophilia B, Acquired Coagulation Factor Deficiency

What are the Type segmentation covered in the Factor IX Complex Drug Market report?

Ans: The Types covered in the Factor IX Complex Drug Market report are Beriplex, Profilnine, Octaplex, Prothromplex, Cofact, Other

Recommended Reports

Hemostasis Therapies

Coagulation Devices

Thrombotic Disorders

1 Factor IX Complex Drug Market Overview

1.1 Product Definition

1.2 Factor IX Complex Drug by Type

1.2.1 Global Factor IX Complex Drug Market Value Comparison by Type (2024 VS 2031)

1.2.2 Beriplex

1.2.3 Profilnine

1.2.4 Octaplex

1.2.5 Prothromplex

1.2.6 Cofact

1.2.7 Other

1.3 Factor IX Complex Drug by Application

1.3.1 Global Factor IX Complex Drug Market Value by Application (2024 VS 2031)

1.3.2 Hemophilia B

1.3.3 Acquired Coagulation Factor Deficiency

1.4 Global Factor IX Complex Drug Market Size Estimates and Forecasts

1.4.1 Global Factor IX Complex Drug Revenue 2020-2031

1.4.2 Global Factor IX Complex Drug Sales 2020-2031

1.4.3 Global Factor IX Complex Drug Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Factor IX Complex Drug Market Competition by Manufacturers

2.1 Global Factor IX Complex Drug Sales Market Share by Manufacturers (2020-2025)

2.2 Global Factor IX Complex Drug Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Factor IX Complex Drug Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Factor IX Complex Drug, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Factor IX Complex Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Factor IX Complex Drug, Product Type & Application

2.7 Global Key Manufacturers of Factor IX Complex Drug, Date of Enter into This Industry

2.8 Global Factor IX Complex Drug Market Competitive Situation and Trends

2.8.1 Global Factor IX Complex Drug Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Factor IX Complex Drug Players Market Share by Revenue

2.8.3 Global Factor IX Complex Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Factor IX Complex Drug Market Scenario by Region

3.1 Global Factor IX Complex Drug Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Factor IX Complex Drug Sales by Region: 2020-2031

3.2.1 Global Factor IX Complex Drug Sales by Region: 2020-2025

3.2.2 Global Factor IX Complex Drug Sales by Region: 2026-2031

3.3 Global Factor IX Complex Drug Revenue by Region: 2020-2031

3.3.1 Global Factor IX Complex Drug Revenue by Region: 2020-2025

3.3.2 Global Factor IX Complex Drug Revenue by Region: 2026-2031

3.4 North America Factor IX Complex Drug Market Facts & Figures by Country

3.4.1 North America Factor IX Complex Drug Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Factor IX Complex Drug Sales by Country (2020-2031)

3.4.3 North America Factor IX Complex Drug Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Factor IX Complex Drug Market Facts & Figures by Country

3.5.1 Europe Factor IX Complex Drug Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Factor IX Complex Drug Sales by Country (2020-2031)

3.5.3 Europe Factor IX Complex Drug Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Factor IX Complex Drug Market Facts & Figures by Region

3.6.1 Asia Pacific Factor IX Complex Drug Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Factor IX Complex Drug Sales by Region (2020-2031)

3.6.3 Asia Pacific Factor IX Complex Drug Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Factor IX Complex Drug Market Facts & Figures by Country

3.7.1 Latin America Factor IX Complex Drug Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Factor IX Complex Drug Sales by Country (2020-2031)

3.7.3 Latin America Factor IX Complex Drug Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Factor IX Complex Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Factor IX Complex Drug Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Factor IX Complex Drug Sales by Country (2020-2031)

3.8.3 Middle East and Africa Factor IX Complex Drug Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Factor IX Complex Drug Sales by Type (2020-2031)

4.1.1 Global Factor IX Complex Drug Sales by Type (2020-2025)

4.1.2 Global Factor IX Complex Drug Sales by Type (2026-2031)

4.1.3 Global Factor IX Complex Drug Sales Market Share by Type (2020-2031)

4.2 Global Factor IX Complex Drug Revenue by Type (2020-2031)

4.2.1 Global Factor IX Complex Drug Revenue by Type (2020-2025)

4.2.2 Global Factor IX Complex Drug Revenue by Type (2026-2031)

4.2.3 Global Factor IX Complex Drug Revenue Market Share by Type (2020-2031)

4.3 Global Factor IX Complex Drug Price by Type (2020-2031)

5 Segment by Application

5.1 Global Factor IX Complex Drug Sales by Application (2020-2031)

5.1.1 Global Factor IX Complex Drug Sales by Application (2020-2025)

5.1.2 Global Factor IX Complex Drug Sales by Application (2026-2031)

5.1.3 Global Factor IX Complex Drug Sales Market Share by Application (2020-2031)

5.2 Global Factor IX Complex Drug Revenue by Application (2020-2031)

5.2.1 Global Factor IX Complex Drug Revenue by Application (2020-2025)

5.2.2 Global Factor IX Complex Drug Revenue by Application (2026-2031)

5.2.3 Global Factor IX Complex Drug Revenue Market Share by Application (2020-2031)

5.3 Global Factor IX Complex Drug Price by Application (2020-2031)

6 Key Companies Profiled

6.1 CSL Behring

6.1.1 CSL Behring Company Information

6.1.2 CSL Behring Description and Business Overview

6.1.3 CSL Behring Factor IX Complex Drug Sales, Revenue and Gross Margin (2020-2025)

6.1.4 CSL Behring Factor IX Complex Drug Product Portfolio

6.1.5 CSL Behring Recent Developments/Updates

6.2 Grifols

6.2.1 Grifols Company Information

6.2.2 Grifols Description and Business Overview

6.2.3 Grifols Factor IX Complex Drug Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Grifols Factor IX Complex Drug Product Portfolio

6.2.5 Grifols Recent Developments/Updates

6.3 Octapharma

6.3.1 Octapharma Company Information

6.3.2 Octapharma Description and Business Overview

6.3.3 Octapharma Factor IX Complex Drug Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Octapharma Factor IX Complex Drug Product Portfolio

6.3.5 Octapharma Recent Developments/Updates

6.4 Prothya Biosolutions

6.4.1 Prothya Biosolutions Company Information

6.4.2 Prothya Biosolutions Description and Business Overview

6.4.3 Prothya Biosolutions Factor IX Complex Drug Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Prothya Biosolutions Factor IX Complex Drug Product Portfolio

6.4.5 Prothya Biosolutions Recent Developments/Updates

6.5 Takeda

6.5.1 Takeda Company Information

6.5.2 Takeda Description and Business Overview

6.5.3 Takeda Factor IX Complex Drug Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Takeda Factor IX Complex Drug Product Portfolio

6.5.5 Takeda Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Factor IX Complex Drug Industry Chain Analysis

7.2 Factor IX Complex Drug Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Factor IX Complex Drug Production Mode & Process Analysis

7.4 Factor IX Complex Drug Sales and Marketing

7.4.1 Factor IX Complex Drug Sales Channels

7.4.2 Factor IX Complex Drug Distributors

7.5 Factor IX Complex Drug Customer Analysis

8 Factor IX Complex Drug Market Dynamics

8.1 Factor IX Complex Drug Industry Trends

8.2 Factor IX Complex Drug Market Drivers

8.3 Factor IX Complex Drug Market Challenges

8.4 Factor IX Complex Drug Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

CSL Behring

Grifols S A

Octapharma AG

Prothya Biosolutions

Takeda

List of Tables

Table 1. Global Factor IX Complex Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Factor IX Complex Drug Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Factor IX Complex Drug Market Competitive Situation by Manufacturers in 2024

Table 4. Global Factor IX Complex Drug Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Factor IX Complex Drug Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Factor IX Complex Drug Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Factor IX Complex Drug Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Factor IX Complex Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Factor IX Complex Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Factor IX Complex Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Factor IX Complex Drug, Product Type & Application

Table 12. Global Key Manufacturers of Factor IX Complex Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Factor IX Complex Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Factor IX Complex Drug as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Factor IX Complex Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Factor IX Complex Drug Sales by Region (2020-2025) & (K Units)

Table 18. Global Factor IX Complex Drug Sales Market Share by Region (2020-2025)

Table 19. Global Factor IX Complex Drug Sales by Region (2026-2031) & (K Units)

Table 20. Global Factor IX Complex Drug Sales Market Share by Region (2026-2031)

Table 21. Global Factor IX Complex Drug Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Factor IX Complex Drug Revenue Market Share by Region (2020-2025)

Table 23. Global Factor IX Complex Drug Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Factor IX Complex Drug Revenue Market Share by Region (2026-2031)

Table 25. North America Factor IX Complex Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Factor IX Complex Drug Sales by Country (2020-2025) & (K Units)

Table 27. North America Factor IX Complex Drug Sales by Country (2026-2031) & (K Units)

Table 28. North America Factor IX Complex Drug Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Factor IX Complex Drug Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Factor IX Complex Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Factor IX Complex Drug Sales by Country (2020-2025) & (K Units)

Table 32. Europe Factor IX Complex Drug Sales by Country (2026-2031) & (K Units)

Table 33. Europe Factor IX Complex Drug Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Factor IX Complex Drug Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Factor IX Complex Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Factor IX Complex Drug Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Factor IX Complex Drug Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Factor IX Complex Drug Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Factor IX Complex Drug Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Factor IX Complex Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Factor IX Complex Drug Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Factor IX Complex Drug Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Factor IX Complex Drug Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Factor IX Complex Drug Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Factor IX Complex Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Factor IX Complex Drug Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Factor IX Complex Drug Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Factor IX Complex Drug Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Factor IX Complex Drug Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Factor IX Complex Drug Sales (K Units) by Type (2020-2025)

Table 51. Global Factor IX Complex Drug Sales (K Units) by Type (2026-2031)

Table 52. Global Factor IX Complex Drug Sales Market Share by Type (2020-2025)

Table 53. Global Factor IX Complex Drug Sales Market Share by Type (2026-2031)

Table 54. Global Factor IX Complex Drug Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Factor IX Complex Drug Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Factor IX Complex Drug Revenue Market Share by Type (2020-2025)

Table 57. Global Factor IX Complex Drug Revenue Market Share by Type (2026-2031)

Table 58. Global Factor IX Complex Drug Price (US$/Unit) by Type (2020-2025)

Table 59. Global Factor IX Complex Drug Price (US$/Unit) by Type (2026-2031)

Table 60. Global Factor IX Complex Drug Sales (K Units) by Application (2020-2025)

Table 61. Global Factor IX Complex Drug Sales (K Units) by Application (2026-2031)

Table 62. Global Factor IX Complex Drug Sales Market Share by Application (2020-2025)

Table 63. Global Factor IX Complex Drug Sales Market Share by Application (2026-2031)

Table 64. Global Factor IX Complex Drug Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Factor IX Complex Drug Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Factor IX Complex Drug Revenue Market Share by Application (2020-2025)

Table 67. Global Factor IX Complex Drug Revenue Market Share by Application (2026-2031)

Table 68. Global Factor IX Complex Drug Price (US$/Unit) by Application (2020-2025)

Table 69. Global Factor IX Complex Drug Price (US$/Unit) by Application (2026-2031)

Table 70. CSL Behring Company Information

Table 71. CSL Behring Description and Business Overview

Table 72. CSL Behring Factor IX Complex Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. CSL Behring Factor IX Complex Drug Product

Table 74. CSL Behring Recent Developments/Updates

Table 75. Grifols Company Information

Table 76. Grifols Description and Business Overview

Table 77. Grifols Factor IX Complex Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Grifols Factor IX Complex Drug Product

Table 79. Grifols Recent Developments/Updates

Table 80. Octapharma Company Information

Table 81. Octapharma Description and Business Overview

Table 82. Octapharma Factor IX Complex Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Octapharma Factor IX Complex Drug Product

Table 84. Octapharma Recent Developments/Updates

Table 85. Prothya Biosolutions Company Information

Table 86. Prothya Biosolutions Description and Business Overview

Table 87. Prothya Biosolutions Factor IX Complex Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Prothya Biosolutions Factor IX Complex Drug Product

Table 89. Prothya Biosolutions Recent Developments/Updates

Table 90. Takeda Company Information

Table 91. Takeda Description and Business Overview

Table 92. Takeda Factor IX Complex Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Takeda Factor IX Complex Drug Product

Table 94. Takeda Recent Developments/Updates

Table 95. Key Raw Materials Lists

Table 96. Raw Materials Key Suppliers Lists

Table 97. Factor IX Complex Drug Distributors List

Table 98. Factor IX Complex Drug Customers List

Table 99. Factor IX Complex Drug Market Trends

Table 100. Factor IX Complex Drug Market Drivers

Table 101. Factor IX Complex Drug Market Challenges

Table 102. Factor IX Complex Drug Market Restraints

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Product Picture of Factor IX Complex Drug

Figure 2. Global Factor IX Complex Drug Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Factor IX Complex Drug Market Share by Type: 2024 & 2031

Figure 4. Beriplex Product Picture

Figure 5. Profilnine Product Picture

Figure 6. Octaplex Product Picture

Figure 7. Prothromplex Product Picture

Figure 8. Cofact Product Picture

Figure 9. Other Product Picture

Figure 10. Global Factor IX Complex Drug Market Value by Application (2020-2031) & (US$ Million)

Figure 11. Global Factor IX Complex Drug Market Share by Application: 2024 & 2031

Figure 12. Hemophilia B

Figure 13. Acquired Coagulation Factor Deficiency

Figure 14. Global Factor IX Complex Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Factor IX Complex Drug Market Size (2020-2031) & (US$ Million)

Figure 16. Global Factor IX Complex Drug Sales (2020-2031) & (K Units)

Figure 17. Global Factor IX Complex Drug Average Price (US$/Unit) & (2020-2031)

Figure 18. Factor IX Complex Drug Report Years Considered

Figure 19. Factor IX Complex Drug Sales Share by Manufacturers in 2024

Figure 20. Global Factor IX Complex Drug Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Factor IX Complex Drug Players: Market Share by Revenue in Factor IX Complex Drug in 2024

Figure 22. Factor IX Complex Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Factor IX Complex Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Factor IX Complex Drug Sales Market Share by Country (2020-2031)

Figure 25. North America Factor IX Complex Drug Revenue Market Share by Country (2020-2031)

Figure 26. United States Factor IX Complex Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Factor IX Complex Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Factor IX Complex Drug Sales Market Share by Country (2020-2031)

Figure 29. Europe Factor IX Complex Drug Revenue Market Share by Country (2020-2031)

Figure 30. Germany Factor IX Complex Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Factor IX Complex Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Factor IX Complex Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Factor IX Complex Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Factor IX Complex Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Factor IX Complex Drug Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Factor IX Complex Drug Revenue Market Share by Region (2020-2031)

Figure 37. China Factor IX Complex Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Factor IX Complex Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Factor IX Complex Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Factor IX Complex Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Factor IX Complex Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. China Taiwan Factor IX Complex Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Southeast Asia Factor IX Complex Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Factor IX Complex Drug Sales Market Share by Country (2020-2031)

Figure 45. Latin America Factor IX Complex Drug Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Factor IX Complex Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Factor IX Complex Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Factor IX Complex Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Colombia Factor IX Complex Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Factor IX Complex Drug Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Factor IX Complex Drug Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Factor IX Complex Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Factor IX Complex Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. UAE Factor IX Complex Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Factor IX Complex Drug by Type (2020-2031)

Figure 56. Global Revenue Market Share of Factor IX Complex Drug by Type (2020-2031)

Figure 57. Global Factor IX Complex Drug Price (US$/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Factor IX Complex Drug by Application (2020-2031)

Figure 59. Global Revenue Market Share of Factor IX Complex Drug by Application (2020-2031)

Figure 60. Global Factor IX Complex Drug Price (US$/Unit) by Application (2020-2031)

Figure 61. Factor IX Complex Drug Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Prothrombin Complex Market Research Report 2024

Human Prothrombin Complex Concentrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prothrombin Complex Concentrate PCC Market Research Report 2024

4 Factor Pro thrombin Complex Concentrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prothrombin Complex Concentrate PCC Drug Market Research Report 2025

Global Activated Prothrombin Complex Concentrate aPCC Market Research Report 2024

Global Coagulation Factor Concentrate Market Research Report 2025

Global Factor IX Deficiency Treatment Market Research Report 2024

Coagulation Factor IX Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Alprolix Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti Inhibitor Coagulant Complex Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Factor IX Complex Market Research Report 2024

Global Recombinant Coagulation Factor Concentrate Market Research Report 2024

Antihemophilic Factor von Willebrand Factor Complex Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Factor VIII Concentrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Precipitated Calcium Carbonate PCC Market Research Report 2025

Global Hemophilia Medication Market Research Report 2024

Global Aprotinin Concentrated Solution Market Research Report 2024

Global Factor Xa Inhibitors Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0I20198

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33W11115

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32E19705

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions